array:5 [
  "content-type" => array:1 [
    0 => "text/html; charset=UTF-8"
  ]
  "cache-control" => array:1 [
    0 => "no-cache, private"
  ]
  "date" => array:1 [
    0 => "Sat, 23 Nov 2024 23:51:31 GMT"
  ]
  "set-cookie" => array:2 [
    0 => "XSRF-TOKEN=eyJpdiI6IjU1VEYrMFpXTlRBbmlrclUvYUFXQlE9PSIsInZhbHVlIjoiemtsSzV6WUR5bVp2eUQ5V25YenN2R0F6NmdkWmpRZEdpMzBlS0laZDYyam53cC9uZTlMLzF2czNFdDA2ZkphWEZhZjZjVXkwRUJLR0NZYXphVXZyK0R3SnJEbURZaHRCbjJ1TTNqS3o1dTRhSTVUWVd6WHpLTmFVNG9CVDUvUzIiLCJtYWMiOiJjNjZlYmE4OGNhMzNlYmY4MDIwNTkxMmM5ZWMyZDc0NDgyNjU5YTQ2ZWU3M2ExMjlmOThiZDU1OGI2N2FlODc4IiwidGFnIjoiIn0%3D; expires=Sun, 23 Nov 2025 23:51:31 GMT; Max-Age=31536000; path=/; secure; samesite=lax"
    1 => "republica_session=eyJpdiI6Inp3RGVSeFVYYWxkeEd1dEcvSnpSRGc9PSIsInZhbHVlIjoiUlplaHNKWmFFcTB5QkZWUVRDNFBBTFg5UEMwU09iV0UycnY2VnREZGI0OXJ5YWNWZGl0SkozTE1GblhNMEwxR2lhVTVxa2diMkJ4d09uK2dCRXAyRWVaMjVZbnVnZDVtNmpNVi9LZXlsVzBXUDFWcnk5S1VhSllENmdUZ09HWmUiLCJtYWMiOiI2MjYxMjVlNmY5M2Y0NWMzODc3YTcxNjQ5MDg2YWQ0ZWZjNTk4MTBhZjMyZmVjNDgxNTU0Y2M3M2JhMTZkMDA0IiwidGFnIjoiIn0%3D; expires=Sun, 23 Nov 2025 23:51:31 GMT; Max-Age=31536000; path=/; secure; httponly; samesite=lax"
  ]
  "Set-Cookie" => array:2 [
    0 => "XSRF-TOKEN=eyJpdiI6IjU1VEYrMFpXTlRBbmlrclUvYUFXQlE9PSIsInZhbHVlIjoiemtsSzV6WUR5bVp2eUQ5V25YenN2R0F6NmdkWmpRZEdpMzBlS0laZDYyam53cC9uZTlMLzF2czNFdDA2ZkphWEZhZjZjVXkwRUJLR0NZYXphVXZyK0R3SnJEbURZaHRCbjJ1TTNqS3o1dTRhSTVUWVd6WHpLTmFVNG9CVDUvUzIiLCJtYWMiOiJjNjZlYmE4OGNhMzNlYmY4MDIwNTkxMmM5ZWMyZDc0NDgyNjU5YTQ2ZWU3M2ExMjlmOThiZDU1OGI2N2FlODc4IiwidGFnIjoiIn0%3D; expires=Sun, 23-Nov-2025 23:51:31 GMT; path=/; secure"
    1 => "republica_session=eyJpdiI6Inp3RGVSeFVYYWxkeEd1dEcvSnpSRGc9PSIsInZhbHVlIjoiUlplaHNKWmFFcTB5QkZWUVRDNFBBTFg5UEMwU09iV0UycnY2VnREZGI0OXJ5YWNWZGl0SkozTE1GblhNMEwxR2lhVTVxa2diMkJ4d09uK2dCRXAyRWVaMjVZbnVnZDVtNmpNVi9LZXlsVzBXUDFWcnk5S1VhSllENmdUZ09HWmUiLCJtYWMiOiI2MjYxMjVlNmY5M2Y0NWMzODc3YTcxNjQ5MDg2YWQ0ZWZjNTk4MTBhZjMyZmVjNDgxNTU0Y2M3M2JhMTZkMDA0IiwidGFnIjoiIn0%3D; expires=Sun, 23-Nov-2025 23:51:31 GMT; path=/; secure; httponly"
  ]
]
'Breakthrough' breast cancer drugs get NHS approval

'Breakthrough' breast cancer drugs get NHS approval

Create an account, or log in
